Loss of heterozygosity at the IGF2R gene and breast cancer
Author Information
Author(s): SA Chappell, T Walsh, RA Walker, JA Shaw
Primary Institution: University of Leicester
Hypothesis
Is loss of heterozygosity at the IGF2R gene an early event in the aetiology of breast cancer?
Conclusion
Loss of heterozygosity at the IGF2R gene is associated with poor differentiation in early breast cancer.
Supporting Evidence
- None of the 40 early invasive carcinomas showed any evidence of LOH.
- 4 out of 18 informative DCIS cases showed clear evidence of LOH.
- Three of the four DCIS cases with LOH were high nuclear-grade cases.
Takeaway
The study found that some early breast cancers lose a specific gene that helps control cell growth, which is linked to more aggressive cancer types.
Methodology
The study analyzed 40 invasive breast carcinomas and 22 cases of ductal carcinoma in situ for loss of heterozygosity at the IGF2R gene using PCR.
Limitations
The study could not perform sequence analysis on cases with LOH due to insufficient DNA.
Participant Demographics
Participants included women with early-stage breast cancer detected by mammography, with no strong family history of breast cancer.
Want to read the original?
Access the complete publication on the publisher's website